
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $221.8M | $96.1M | $101.2M | $88.9M | |
Revenue Growth (YoY) | -- | -- | -56.67% | 5.27% | -12.17% | |
Cost of Revenues | -- | $217.1M | $113.3M | $130.1M | $114.4M | |
Gross Profit | -- | $4.7M | -$17.2M | -$28.9M | -$25.6M | |
Gross Profit Margin | -- | 2.14% | -17.93% | -28.6% | -28.78% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $46.3M | $10.9M | $16.5M | $3.6M | |
Other Inc / (Exp) | -- | $126.2M | $55.8M | -$143.5M | -$62.9M | |
Operating Expenses | -- | $23.9M | $45.2M | $3.1M | -$13.5M | |
Operating Income | -- | -$19.2M | -$62.5M | -$32M | -$12.1M | |
Net Interest Expenses | -- | $21.8M | $29.7M | $20.8M | $13.4M | |
EBT. Incl. Unusual Items | -- | $85.2M | -$36.3M | -$196.3M | -$88.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | $22.5M | -- | -- | $2K | |
Net Income to Company | -- | $62.7M | -$36.3M | -$196.3M | -$88.4M | |
Minority Interest in Earnings | -- | $74K | -$37K | -$66K | $1.6M | |
Net Income to Common Excl Extra Items | -- | $62.7M | -$36.3M | -$196.4M | -$86.8M | |
Basic EPS (Cont. Ops) | -- | $4.71 | -$2.73 | -$14.74 | -$6.51 | |
Diluted EPS (Cont. Ops) | -- | $4.71 | -$2.73 | -$14.74 | -$6.51 | |
Weighted Average Basic Share | -- | $13.3M | $13.3M | $13.3M | $13.3M | |
Weighted Average Diluted Share | -- | $13.3M | $13.3M | $13.3M | $13.3M | |
EBITDA | -- | $143.1M | $10.6M | -$168.7M | -$68.3M | |
EBIT | -- | $136.6M | $5.7M | -$173.3M | -$72.6M | |
Revenue (Reported) | -- | $221.8M | $96.1M | $101.2M | $88.9M | |
Operating Income (Reported) | -- | -$19.2M | -$62.5M | -$32M | -$12.1M | |
Operating Income (Adjusted) | -- | $136.6M | $5.7M | -$173.3M | -$72.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $20M | $13.4M | $20.5M | $9M | |
Revenue Growth (YoY) | -- | -- | -33.21% | 53.36% | -55.91% | |
Cost of Revenues | -- | $24.4M | $19.6M | $24.1M | $16.5M | |
Gross Profit | -- | -$4.4M | -$6.2M | -$3.6M | -$7.5M | |
Gross Profit Margin | -- | -21.77% | -46.43% | -17.69% | -82.82% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $944K | $14.1M | $7.4M | $4.7M | |
Other Inc / (Exp) | -- | $12.5M | -$61M | -$37.9M | $3.2M | |
Operating Expenses | -- | $305K | $14.6M | $4M | $1.1M | |
Operating Income | -- | -$4.7M | -$20.8M | -$7.7M | -$8.6M | |
Net Interest Expenses | -- | $8.4M | $9M | $3.4M | $2.7M | |
EBT. Incl. Unusual Items | -- | -$538K | -$90.7M | -$49M | -$8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $2K | -- | |
Net Income to Company | -- | -$538K | -$90.7M | -$49M | -$8M | |
Minority Interest in Earnings | -- | $18K | $25K | $15K | $442K | |
Net Income to Common Excl Extra Items | -- | -$520K | -$90.7M | -$49M | -$7.6M | |
Basic EPS (Cont. Ops) | -- | -$0.04 | -$6.81 | -$3.68 | -$0.57 | |
Diluted EPS (Cont. Ops) | -- | -$0.04 | -$6.81 | -$3.68 | -$0.57 | |
Weighted Average Basic Share | -- | $13.3M | $13.3M | $13.3M | $13.3M | |
Weighted Average Diluted Share | -- | $13.3M | $13.3M | $13.3M | $13.3M | |
EBITDA | -- | $13.9M | -$79.6M | -$44M | -$3.3M | |
EBIT | -- | $12.7M | -$80.6M | -$45.2M | -$4.3M | |
Revenue (Reported) | -- | $20M | $13.4M | $20.5M | $9M | |
Operating Income (Reported) | -- | -$4.7M | -$20.8M | -$7.7M | -$8.6M | |
Operating Income (Adjusted) | -- | $12.7M | -$80.6M | -$45.2M | -$4.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | -- | $97.6M | $108.4M | $77.4M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | -- | $108.5M | $134.7M | $106.8M | |
Gross Profit | -- | -- | -$11M | -$26.3M | -$29.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | -- | $24.1M | $9.8M | $946K | |
Other Inc / (Exp) | -- | $12.5M | -$17.6M | -$120.4M | -$21.8M | |
Operating Expenses | -- | -- | $67.6M | -$7.4M | -$16.5M | |
Operating Income | -- | -- | -$78.6M | -$18.9M | -$12.9M | |
Net Interest Expenses | -- | $8.4M | $30.3M | $15.3M | $12.7M | |
EBT. Incl. Unusual Items | -- | -- | -$126.5M | -$154.5M | -$47.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $2K | -- | |
Net Income to Company | -- | -- | -$126.5M | -$154.5M | -$47.4M | |
Minority Interest in Earnings | -- | $18K | -$30K | -$76K | $2M | |
Net Income to Common Excl Extra Items | -- | -- | -$126.5M | -$154.6M | -$45.4M | |
Basic EPS (Cont. Ops) | -- | -- | -$9.50 | -$11.60 | -$3.41 | |
Diluted EPS (Cont. Ops) | -- | -- | -$9.50 | -$11.60 | -$3.41 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | -- | -- | -$82.8M | -$133.2M | -$27.6M | |
EBIT | -- | -- | -$87.6M | -$137.9M | -$31.7M | |
Revenue (Reported) | -- | -- | $97.6M | $108.4M | $77.4M | |
Operating Income (Reported) | -- | -- | -$78.6M | -$18.9M | -$12.9M | |
Operating Income (Adjusted) | -- | -- | -$87.6M | -$137.9M | -$31.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | -- | $20M | $13.4M | $20.5M | $9M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | -- | $24.4M | $19.6M | $24.1M | $16.5M | |
Gross Profit | -- | -$4.4M | -$6.2M | -$3.6M | -$7.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | -- | $944K | $14.1M | $7.4M | $4.7M | |
Other Inc / (Exp) | -- | $12.5M | -$61M | -$37.9M | $3.2M | |
Operating Expenses | -- | $305K | $14.6M | $4M | $1.1M | |
Operating Income | -- | -$4.7M | -$20.8M | -$7.7M | -$8.6M | |
Net Interest Expenses | -- | $8.4M | $9M | $3.4M | $2.7M | |
EBT. Incl. Unusual Items | -- | -$538K | -$90.7M | -$49M | -$8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -- | -- | -- | $2K | -- | |
Net Income to Company | -- | -$538K | -$90.7M | -$49M | -$8M | |
Minority Interest in Earnings | -- | $18K | $25K | $15K | $442K | |
Net Income to Common Excl Extra Items | -- | -$520K | -$90.7M | -$49M | -$7.6M | |
Basic EPS (Cont. Ops) | -- | -$0.04 | -$6.81 | -$3.68 | -$0.57 | |
Diluted EPS (Cont. Ops) | -- | -$0.04 | -$6.81 | -$3.68 | -$0.57 | |
Weighted Average Basic Share | -- | $13.3M | $13.3M | $13.3M | $13.3M | |
Weighted Average Diluted Share | -- | $13.3M | $13.3M | $13.3M | $13.3M | |
EBITDA | -- | $13.9M | -$79.6M | -$44M | -$3.3M | |
EBIT | -- | $12.7M | -$80.6M | -$45.2M | -$4.3M | |
Revenue (Reported) | -- | $20M | $13.4M | $20.5M | $9M | |
Operating Income (Reported) | -- | -$4.7M | -$20.8M | -$7.7M | -$8.6M | |
Operating Income (Adjusted) | -- | $12.7M | -$80.6M | -$45.2M | -$4.3M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | $4.2M | $50.7M | $35M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | -- | $97.9M | $85.4M | $100.1M | |
Property Plant And Equipment | -- | -- | $234M | $182.9M | $177.4M | |
Long-Term Investments | -- | -- | $587.1M | $316.5M | $249.9M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | $9.5M | $8.9M | $8.2M | |
Total Assets | -- | -- | $1B | $669.2M | $608.7M | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | $4.9M | $5.9M | $11.9M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | -- | $28.6M | $231M | $260.4M | |
Long-Term Debt | -- | -- | -- | -- | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $33.1M | $235.4M | $263.7M | |
Common Stock | -- | -- | -- | $13K | $13K | |
Other Common Equity Adj | -- | -- | -- | $359K | -$104K | |
Common Equity | -- | -- | $971.5M | $411.6M | $324.3M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | $726K | $22.3M | $20.7M | |
Total Equity | -- | -- | $972.3M | $433.8M | $345M | |
Total Liabilities and Equity | -- | -- | $1B | $669.2M | $608.7M | |
Cash and Short Terms | -- | -- | $4.2M | $50.7M | $35M | |
Total Debt | -- | -- | -- | $192.9M | $217.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | -- | -- | $70.2M | $45.7M | $30.3M | |
Short Term Investments | -- | -- | -- | -- | $14.7M | |
Accounts Receivable, Net | -- | -- | -- | -- | -- | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | -- | -- | -- | -- | -- | |
Total Current Assets | -- | -- | $92.7M | $82.5M | $94.5M | |
Property Plant And Equipment | -- | -- | $224.5M | $178.9M | $190.3M | |
Long-Term Investments | -- | -- | $397.9M | $278.6M | $253.1M | |
Goodwill | -- | -- | -- | -- | -- | |
Other Intangibles | -- | -- | -- | -- | -- | |
Other Long-Term Assets | -- | -- | $18.9M | $8.1M | $7.7M | |
Total Assets | -- | -- | $813.1M | $622.9M | $618.2M | |
Accounts Payable | -- | -- | -- | -- | -- | |
Accrued Expenses | -- | -- | -- | $6M | $14.9M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | -- | -- | $289.2M | $235M | $47.8M | |
Long-Term Debt | -- | -- | -- | -- | $231.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | -- | -- | $292.5M | $238.2M | $281.9M | |
Common Stock | -- | -- | $13K | $13K | $13K | |
Other Common Equity Adj | -- | -- | -- | $206K | -$698K | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | $3.8M | $22.3M | $20.2M | |
Total Equity | -- | -- | $520.6M | $384.7M | $336.4M | |
Total Liabilities and Equity | -- | -- | $813.1M | $622.9M | $618.2M | |
Cash and Short Terms | -- | -- | $70.2M | $45.7M | $45M | |
Total Debt | -- | -- | $251.8M | $195M | $231.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | $62.7M | -$36.3M | -$196.3M | -$88.4M | |
Depreciation & Amoritzation | -- | $6.5M | $4.9M | $4.6M | $4.3M | |
Stock-Based Compensation | -- | $23.4M | -$11.8M | $1.8M | -- | |
Change in Accounts Receivable | -- | $5.2M | $491K | $570K | -$378K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | $8.5M | -$27.4M | -$18.7M | -$31.3M | |
Capital Expenditures | -- | $24.6M | $22.5M | $14.1M | $35.9M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | $673.1M | $236.1M | $186M | $306K | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | $253.1M | $15.8M | |
Long-Term Debt Repaid | -- | -- | -- | -$69.8M | -- | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -$676.4M | -$218.3M | -$297.3M | -- | |
Cash From Financing | -- | -$676.4M | -$218.3M | -$114.1M | $15.8M | |
Beginning Cash (CF) | -- | $11.9M | $17.1M | $7.5M | $60.7M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $5.2M | -$9.6M | $53.2M | -$15.2M | |
Ending Cash (CF) | -- | $17.1M | $7.5M | $60.7M | $45.5M | |
Levered Free Cash Flow | -- | -$16.1M | -$49.8M | -$32.8M | -$67.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$538K | -$90.7M | -$49M | -$8M | |
Depreciation & Amoritzation | -- | $1.2M | $1.1M | $1.2M | $977K | |
Stock-Based Compensation | -- | -$4.6M | $1.8M | -- | -- | |
Change in Accounts Receivable | -- | $135K | $59K | $287K | $211K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$10.8M | -$554K | -$14.2M | -$6.3M | |
Capital Expenditures | -- | $4.9M | $2.2M | $6.2M | $16.5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$68.7M | $116.8M | $9.6M | -$8.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $253.1M | -- | $17.3M | |
Long-Term Debt Repaid | -- | -- | -$10M | -- | -$5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $82.7M | -$291.3M | -- | -$251K | |
Cash From Financing | -- | $82.7M | -$48.3M | -- | $12.1M | |
Beginning Cash (CF) | -- | $17.1M | $7.5M | $60.7M | $45.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $3.2M | $68M | -$4.6M | -$2.5M | |
Ending Cash (CF) | -- | $20.3M | $75.4M | $56.1M | $43M | |
Levered Free Cash Flow | -- | -$15.7M | -$2.8M | -$20.4M | -$22.8M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -- | -$126.5M | -$154.5M | -$47.4M | |
Depreciation & Amoritzation | -- | -- | $4.8M | $4.7M | $4.1M | |
Stock-Based Compensation | -- | -$4.6M | -$5.4M | -- | -- | |
Change in Accounts Receivable | -- | -- | $415K | $798K | -$454K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -- | -$17.2M | -$32.4M | -$23.4M | |
Capital Expenditures | -- | $4.9M | $19.8M | $18M | $46.2M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -- | $421.6M | $78.9M | -$17.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | $253.1M | -- | $33.2M | |
Long-Term Debt Repaid | -- | -- | -$10M | -$59.8M | -$5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | -- | -$592.3M | -- | -- | |
Cash From Financing | -- | -- | -$349.2M | -$65.8M | $27.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | -- | $55.2M | -$19.3M | -$13.1M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | -- | -- | -$36.9M | -$50.4M | -$69.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -- | -$538K | -$90.7M | -$49M | -$8M | |
Depreciation & Amoritzation | -- | $1.2M | $1.1M | $1.2M | $977K | |
Stock-Based Compensation | -- | -$4.6M | $1.8M | -- | -- | |
Change in Accounts Receivable | -- | $135K | $59K | $287K | $211K | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -- | -$10.8M | -$554K | -$14.2M | -$6.3M | |
Capital Expenditures | -- | $4.9M | $2.2M | $6.2M | $16.5M | |
Cash Acquisitions | -- | -- | -- | -- | -- | |
Cash From Investing | -- | -$68.7M | $116.8M | $9.6M | -$8.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | $253.1M | -- | $17.3M | |
Long-Term Debt Repaid | -- | -- | -$10M | -- | -$5M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -- | $82.7M | -$291.3M | -- | -$251K | |
Cash From Financing | -- | $82.7M | -$48.3M | -- | $12.1M | |
Beginning Cash (CF) | -- | $17.1M | $7.5M | $60.7M | $45.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -- | $3.2M | $68M | -$4.6M | -$2.5M | |
Ending Cash (CF) | -- | $20.3M | $75.4M | $56.1M | $43M | |
Levered Free Cash Flow | -- | -$15.7M | -$2.8M | -$20.4M | -$22.8M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.